165 related articles for article (PubMed ID: 32884437)
1. The effect of Hangeshashinto on Oral Mucositis Caused by Induction Chemotherapy in Patients with Head and Neck Cancer.
Taira K; Fujiwara K; Fukuhara T; Koyama S; Takeuchi H
Yonago Acta Med; 2020 Aug; 63(3):183-187. PubMed ID: 32884437
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
Matsuda C; Munemoto Y; Mishima H; Nagata N; Oshiro M; Kataoka M; Sakamoto J; Aoyama T; Morita S; Kono T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):97-103. PubMed ID: 25983022
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
Aoyama T; Nishikawa K; Takiguchi N; Tanabe K; Imano M; Fukushima R; Sakamoto J; Oba MS; Morita S; Kono T; Tsuburaya A
Cancer Chemother Pharmacol; 2014 May; 73(5):1047-54. PubMed ID: 24652604
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C).
Nishikawa K; Aoyama T; Oba MS; Yoshikawa T; Matsuda C; Munemoto Y; Takiguchi N; Tanabe K; Nagata N; Imano M; Oshiro M; Fukushima R; Kataoka M; Morita S; Tsuburaya A; Mishima H; Kono T; Sakamoto J
J Cancer; 2018; 9(10):1725-1730. PubMed ID: 29805697
[No Abstract] [Full Text] [Related]
5. A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion.
Yamashita T; Araki K; Tomifuji M; Kamide D; Tanaka Y; Shiotani A
Support Care Cancer; 2015 Jan; 23(1):29-35. PubMed ID: 24943276
[TBL] [Abstract][Full Text] [Related]
6. Topical Application of Hangeshashinto (TJ-14) in the Treatment of Chemotherapy-Induced Oral Mucositis.
Kono T; Satomi M; Chisato N; Ebisawa Y; Suno M; Asama T; Karasaki H; Matsubara K; Furukawa H
World J Oncol; 2010 Dec; 1(6):232-235. PubMed ID: 29147213
[TBL] [Abstract][Full Text] [Related]
7. Hangeshashinto for prevention of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized phase II study.
Yoshimatsu M; Kawashita Y; Soutome S; Murata M; Sawayama Y; Kurogi T; Nakao N; Miyazaki Y; Umeda M; Ukai T
Support Care Cancer; 2023 Nov; 31(12):707. PubMed ID: 37979045
[TBL] [Abstract][Full Text] [Related]
8. Hangeshashinto improves the completion rate of chemoradiotherapy and the nutritional status in patients with head and neck cancer.
Hatakeyama H; Takahashi H; Oridate N; Kuramoto R; Fujiwara K; Homma A; Takeda H; Fukuda S
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):100-8. PubMed ID: 25896416
[TBL] [Abstract][Full Text] [Related]
9. Effects of Topical Hangeshashinto (TJ-14) on Chemotherapy-Induced Oral Mucositis.
Ozawa N; Onda T; Hayashi K; Honda H; Shibahara T
Cancer Manag Res; 2020; 12():1069-1078. PubMed ID: 32104087
[TBL] [Abstract][Full Text] [Related]
10. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of Zataria extract mouthwash for the management of radiation-induced oral mucositis in patients: a randomized placebo-controlled double-blind study.
Aghamohammadi A; Moslemi D; Akbari J; Ghasemi A; Azadbakht M; Asgharpour A; Hosseinimehr SJ
Clin Oral Investig; 2018 Jul; 22(6):2263-2272. PubMed ID: 29313134
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial.
Lalla RV; Solé S; Becerra S; Carvajal C; Bettoli P; Letelier H; Santini A; Vargas L; Cifuentes A; Larsen F; Jara N; Oyarzún J; Feinn R; Bustamante E; Martínez B; Rosenberg D; Galván T
Support Care Cancer; 2020 Dec; 28(12):5871-5879. PubMed ID: 32266567
[TBL] [Abstract][Full Text] [Related]
13. Hangeshashinto (TJ-14) prevents radiation-induced mucositis by suppressing cyclooxygenase-2 expression and chemotaxis of inflammatory cells.
Kamide D; Yamashita T; Araki K; Tomifuji M; Shiotani A
Clin Transl Oncol; 2017 Nov; 19(11):1329-1336. PubMed ID: 28516399
[TBL] [Abstract][Full Text] [Related]
14. Ketamine mouthwash versus placebo in the treatment of severe oral mucositis pain in children with cancer: A randomized double-blind placebo-controlled trial.
Prakash S; Meena JP; Gupta AK; Bakhshi S; Velpandian T; Pandey RM; Seth R
Pediatr Blood Cancer; 2020 Sep; 67(9):e28573. PubMed ID: 32648983
[TBL] [Abstract][Full Text] [Related]
15. Effects of nanomicelle curcumin capsules on prevention and treatment of oral mucosits in patients under chemotherapy with or without head and neck radiotherapy: a randomized clinical trial.
Kia SJ; Basirat M; Saedi HS; Arab SA
BMC Complement Med Ther; 2021 Sep; 21(1):232. PubMed ID: 34521398
[TBL] [Abstract][Full Text] [Related]
16. Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy.
Peterson DE; Barker NP; Akhmadullina LI; Rodionova I; Sherman NZ; Davidenko IS; Rakovskaya GN; Gotovkin EA; Shinkarev SA; Kopp MV; Kulikov EP; Moiseyenko VM; Gertner JM; Firsov I; Tuleneva T; Yarosh A; Woon CW
J Clin Oncol; 2009 Sep; 27(26):4333-8. PubMed ID: 19636011
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of erythropoietin mouthwash in prevention of oral mucositis in patients undergoing autologous hematopoietic SCT: a double-blind, randomized, placebo-controlled trial.
Hosseinjani H; Hadjibabaie M; Gholami K; Javadi M; Radfar M; Jahangard-Rafsanjani Z; Hosseinjani E; Shabani N; Vaezi M; Ghavamzadeh A
Hematol Oncol; 2017 Mar; 35(1):106-112. PubMed ID: 26310513
[TBL] [Abstract][Full Text] [Related]
18. Effects of an Indomethacin Oral Spray on Pain Due to Oral Mucositis in Cancer Patients Treated With Radiotherapy and Chemotherapy: A Double-Blind, Randomized, Placebo-Controlled Trial (JORTC-PAL04).
Nagaoka H; Momo K; Hamano J; Miyaji T; Oyamada S; Kawaguchi T; Homma M; Yamaguchi T; Morita T; Kizawa Y
J Pain Symptom Manage; 2021 Sep; 62(3):537-544. PubMed ID: 33516927
[TBL] [Abstract][Full Text] [Related]
19. A double blind randomised placebo controlled study of propolis (bee glue) effectiveness in the treatment of severe oral mucositis in chemotherapy treated children.
Tomaževič T; Jazbec J
Complement Ther Med; 2013 Aug; 21(4):306-12. PubMed ID: 23876561
[TBL] [Abstract][Full Text] [Related]
20. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial.
Legouté F; Bensadoun RJ; Seegers V; Pointreau Y; Caron D; Lang P; Prévost A; Martin L; Schick U; Morvant B; Capitain O; Calais G; Jadaud E
Radiat Oncol; 2019 May; 14(1):83. PubMed ID: 31118057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]